1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. FRESH TRACKS THERAPEUTICS INC

Fresh Tracks Therapeutics Inc

XNAS: FRTX

Watchlist

Portfolio

Share


Insider Trading disclosures for Fresh Tracks Therapeutics Inc

The latest disclosure was made by N. Albert Marchio in Fresh Tracks Therapeutics Inc where a trade of 1,250 Restricted Stock Units done was reported to US exchanges on Dec. 28, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
N. Albert Marchio Director, CEO and CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Dec 2023 1,250 0 - - Restricted Stock Units
Aaron Fox-Collis VP of Finance & CAO Sale or transfer of securities back to the company at price $ 0.00 per share. 28 Dec 2023 8,000 0 - - Restricted Stock Units
Aaron Fox-Collis VP of Finance & CAO Sale of securities on an exchange or to another person at price $ 0.91 per share. 08 Dec 2023 74 0 (0%) 0% 0.9 67 Common Stock
Aaron Fox-Collis VP of Finance & CAO Sale of securities on an exchange or to another person at price $ 0.86 per share. 04 Dec 2023 36 74 (0%) 0% 0.9 31 Common Stock
Deepak Chadha Former Chief R&D Officer & COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2023 35,000 0 - - Restricted Stock Units
Chadha Deepak Former Chief R&D Officer & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. 01 Sep 2023 14,978 22,314 (0%) 0% 0.6 9,301 Common Stock
Deepak Chadha Former Chief R&D Officer & COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2023 35,000 37,292 (0%) 0% - Common Stock
Albert N. Marchio Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2023 1,250 1,250 - - Restricted Stock Units
Deepak Chadha Chief R&D Officer and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2023 35,000 35,000 - - Restricted Stock Units
David R. McAvoy Gen Counsel, CCO, & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2023 20,000 20,000 - - Restricted Stock Units
Andrew D. Sklawer President Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2023 55,000 55,000 - - Restricted Stock Units
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 65,000 65,000 - - Stock Option (right to buy)
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 65,000 65,000 - - Stock Option (right to buy)
Reginald L. Hardy Director, CHAIRMAN OF THE BOARD Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 65,000 65,000 - - Stock Option (right to buy)
Albert N. Marchio Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 30,000 30,000 - - Stock Option (right to buy)
Deepak Chadha Chief Research & Dev. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 325,000 325,000 - - Stock Option (right to buy)
Monica E. Luchi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 325,000 325,000 - - Stock Option (right to buy)
David R. McAvoy General Counsel and CCO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 300,000 300,000 - - Stock Option (right to buy)
Robert Busard Brown Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 1,100,000 1,100,000 - - Stock Option (right to buy)
Andrew D. Sklawer COO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 450,000 450,000 - - Stock Option (right to buy)
Jose Breton Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 150,000 150,000 - - Stock Option (right to buy)
Reginald L. Hardy Director, CHAIRMAN OF THE BOARD Purchase of securities on an exchange or from another person at price $ 0.66 per share. 23 Jul 2021 100,000 348,411 (3%) 1% 0.7 66,230 Common Stock
Reginald L. Hardy Director, CHAIRMAN OF THE BOARD Purchase of securities on an exchange or from another person at price $ 0.67 per share. 23 Jul 2021 100,000 448,411 (4%) 1% 0.7 67,420 Common Stock
David R. McAvoy General Counsel and CCO Purchase of securities on an exchange or from another person at price $ 0.67 per share. 23 Jul 2021 18,124 128,879 (1%) 0% 0.7 12,138 Common Stock
Albert N. Marchio Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 20,000 20,000 - - Stock Option (right to buy)
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Reginald L. Hardy Director, CHAIRMAN OF THE BOARD Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Deepak Chadha Chief Research & Dev. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 250,000 250,000 - - Stock Option (right to buy)
David R. McAvoy General Counsel and CCO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 200,000 200,000 - - Stock Option (right to buy)
Robert Busard Brown Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 750,000 750,000 - - Stock Option (right to buy)
Andrew D. Sklawer COO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 250,000 250,000 - - Stock Option (right to buy)
Jose Breton Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 85,000 85,000 - - Stock Option (right to buy)
Deepak Chadha Chief Research & Dev. Officer Purchase of securities on an exchange or from another person at price $ 0.82 per share. 18 May 2021 2,700 65,667 (0%) 0% 0.8 2,212 Common Stock
Deepak Chadha Chief Research & Dev. Officer Purchase of securities on an exchange or from another person at price $ 0.83 per share. 18 May 2021 12,500 78,167 (0%) 0% 0.8 10,378 Common Stock
David R. McAvoy General Counsel and CCO Purchase of securities on an exchange or from another person at price $ 0.80 per share. 17 May 2021 18,622 110,755 (1%) 0% 0.8 14,898 Common Stock
David R. McAvoy General Counsel and CCO Purchase of securities on an exchange or from another person at price $ 0.80 per share. 17 May 2021 7,980 13,980 (0%) 0% 0.8 6,384 Common Stock
Andrew D. Sklawer COO and Secretary Purchase of securities on an exchange or from another person at price $ 0.80 per share. 17 May 2021 15,375 124,625 (1%) 0% 0.8 12,300 Common Stock
Deepak Chadha Chief Research & Dev. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 25,000 71,717 (0%) 0% - Common Stock
Deepak Chadha Chief Research & Dev. Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 25,000 0 - - Restricted Stock Units
Deepak Chadha Chief Research & Dev. Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. 16 Mar 2021 8,750 62,967 (0%) 0% 1.1 9,975 Common Stock
David R. McAvoy General Counsel and CCO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. 16 Mar 2021 8,750 92,133 (0%) 0% 1.1 9,975 Common Stock
David R. McAvoy General Counsel and CCO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 25,000 0 - - Restricted Stock Units
David R. McAvoy General Counsel and CCO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 25,000 100,883 (1%) 0% - Common Stock
Andrew D. Sklawer COO and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. 16 Mar 2021 7,000 109,250 (1%) 0% 1.1 7,980 Common Stock
Andrew D. Sklawer COO and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 20,000 0 - - Restricted Stock Units
Andrew D. Sklawer COO and Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 20,000 116,250 (1%) 0% - Common Stock
Jose Breton Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. 16 Mar 2021 5,250 11,919 (0%) 0% 1.1 5,985 Common Stock
Jose Breton Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 15,000 0 - - Restricted Stock Units
Jose Breton Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 15,000 17,169 (0%) 0% - Common Stock
Robert Busard Brown Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.18 per share. 15 Mar 2021 100,000 186,957 (1%) 1% 1.2 117,780 Common Stock
David R. McAvoy General Counsel and CCO Purchase of securities on an exchange or from another person at price $ 0.83 per share. 18 Sep 2020 16,526 75,883 (0%) 0% 0.8 13,713 Common Stock
David R. McAvoy General Counsel and CCO Purchase of securities on an exchange or from another person at price $ 0.84 per share. 18 Sep 2020 6,000 6,000 (0%) 0% 0.8 5,039 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.81 per share. 15 Sep 2020 11,934 24,729 (0%) 0% 0.8 9,667 Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 60,000 60,000 - - Stock Option (right to buy)
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 60,000 60,000 - - Stock Option (right to buy)
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.81 per share. 15 Sep 2020 10,493 23,542 (0%) 0% 0.8 8,499 Common Stock
Reginald L. Hardy Director, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.81 per share. 15 Sep 2020 15,226 205,849 (2%) 0% 0.8 12,333 Common Stock
Reginald L. Hardy Director, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 60,000 60,000 - - Stock Option (right to buy)
Deepak Chadha Chief Research & Dev. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 400,000 400,000 - - Stock Option (right to buy)
David R. McAvoy General Counsel and CCO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 350,000 350,000 - - Stock Option (right to buy)
Robert Busard Brown Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 1,000,000 1,000,000 - - Stock Option (right to buy)
Andrew D. Sklawer COO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 450,000 450,000 - - Stock Option (right to buy)
Jose Breton Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 150,000 150,000 - - Stock Option (right to buy)
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. 31 Aug 2020 346 21,426 (0%) 0% 0.9 325 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2020 692 0 - - Restricted Stock Units
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2020 692 21,772 (0%) 0% - Common Stock
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. 31 Aug 2020 8,631 12,795 (0%) 0% 0.9 8,113 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2020 609 0 - - Restricted Stock Units
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. 31 Aug 2020 6,375 13,049 (0%) 0% 0.9 5,993 Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. 31 Aug 2020 256 19,424 (0%) 0% 0.9 241 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2020 609 19,680 (0%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2020 883 197,954 (2%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2020 883 0 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. 31 Aug 2020 283 197,671 (2%) 0% 0.9 266 Common Stock
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. 31 Aug 2020 7,048 190,623 (1%) 0% 0.9 6,625 Common Stock
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. 31 Jul 2020 346 21,080 (0%) 0% 0.9 318 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 692 21,426 (0%) 0% - Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 692 692 - - Restricted Stock Units
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 608 19,327 (0%) 0% - Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. 31 Jul 2020 256 19,071 (0%) 0% 0.9 236 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 608 609 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 882 883 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. 31 Jul 2020 283 197,071 (2%) 0% 0.9 260 Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 882 197,354 (2%) 0% - Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2020 691 1,384 - - Restricted Stock Units
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. 30 Jun 2020 346 20,734 (0%) 0% 1 346 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2020 691 21,080 (0%) 0% - Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. 30 Jun 2020 256 18,719 (0%) 0% 1 256 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2020 608 1,217 - - Restricted Stock Units
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2020 608 18,975 (0%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2020 883 1,765 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2020 883 196,755 (2%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. 30 Jun 2020 283 196,472 (2%) 0% 1 283 Common Stock
Deepak Chadha Chief Research & Dev. Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 26,087 46,717 (0%) 0% - Common Stock
Deepak Chadha Chief Research & Dev. Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 26,087 26,087 - - Common Stock Warrants (right to buy)
David R. McAvoy General Counsel and CCO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 30,435 59,357 (0%) 0% - Common Stock
David R. McAvoy General Counsel and CCO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 30,435 30,435 - - Common Stock Warrants (right to buy)
Robert Busard Brown Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 86,957 86,957 - - Common Stock Warrants (right to buy)
Robert Busard Brown Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 86,957 86,957 (0%) 0% - Common Stock
Andrew D. Sklawer COO and Secretary Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 13,044 13,044 - - Common Stock Warrants (right to buy)
Andrew D. Sklawer COO and Secretary Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2020 13,044 96,250 (0%) 0% - Common Stock
R. Michael Carruthers Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 10,000 10,000 - - Restricted Stock Units
Deepak Chadha Chief Research & Dev. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 25,000 25,000 - - Restricted Stock Units
Adam S. Levy Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 20,000 20,000 - - Restricted Stock Units
David R. McAvoy General Counsel and CCO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 25,000 25,000 - - Restricted Stock Units
Andrew D. Sklawer COO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 20,000 20,000 - - Restricted Stock Units
Jose Breton Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 15,000 15,000 - - Restricted Stock Units
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 14 Feb 2020 346 2,091 (0%) 0% 2.9 1,014 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 692 2,437 (0%) 0% - Common Stock
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. 14 Feb 2020 1,746 1,745 (0%) 0% 1.2 2,025 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 3,491 3,491 (0%) 0% - Common Stock
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 2,167 2,167 - - Stock Options
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 8,333 8,333 - - Restricted Stock Units
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 4,333 4,333 - - Stock Option (right to buy)
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 692 692 - - Restricted Stock Units
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 692 692 - - Restricted Stock Units
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 691 691 - - Restricted Stock Units
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 692 692 - - Restricted Stock Units
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 3,491 3,491 - - Restricted Stock Units
Gary A. Lyons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 17,261 20,389 (0%) 0% 0 Common Stock
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. 14 Feb 2020 346 3,128 (0%) 0% 1.2 401 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 692 3,474 (0%) 0% - Common Stock
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 14 Feb 2020 346 2,782 (0%) 0% 1.2 415 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 692 3,128 (0%) 0% - Common Stock
Gary A. Lyons Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. 14 Feb 2020 346 2,436 (0%) 0% 1.2 412 Common Stock
Gary A. Lyons Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 691 2,782 (0%) 0% - Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 3,070 3,070 - - Restricted Stock Units
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 2,167 2,167 - - Stock Options
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 7,328 7,328 - - Restricted Stock Units
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 4,333 4,333 - - Stock Option (right to buy)
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 608 608 - - Restricted Stock Units
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 609 609 - - Restricted Stock Units
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 608 608 - - Restricted Stock Units
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 608 608 - - Restricted Stock Units
Vijay B. Samant Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 15,178 18,367 (0%) 0% 0 Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. 14 Feb 2020 256 3,189 (0%) 0% 1.2 297 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 608 3,445 (0%) 0% - Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 14 Feb 2020 256 2,837 (0%) 0% 1.2 307 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 609 3,093 (0%) 0% - Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. 14 Feb 2020 256 2,484 (0%) 0% 1.2 305 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 608 2,740 (0%) 0% - Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 14 Feb 2020 256 2,132 (0%) 0% 2.9 750 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 608 2,388 (0%) 0% - Common Stock
Vijay B. Samant Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. 14 Feb 2020 1,290 1,780 (0%) 0% 1.2 1,496 Common Stock
Vijay B. Samant Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 3,070 3,070 (0%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 4,454 172,877 (1%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 5,333 5,333 - - Stock Option (right to buy)
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 882 882 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 10,632 10,632 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 883 883 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 882 882 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 883 883 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 4,454 4,454 - - Restricted Stock Units
Reginald L. Hardy Director, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 22,023 195,872 (2%) 0% 0 Common Stock
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. 14 Feb 2020 283 173,849 (1%) 0% 1.2 328 Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 882 174,132 (1%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 14 Feb 2020 283 173,250 (1%) 0% 1.2 340 Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 883 173,533 (1%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. 14 Feb 2020 283 172,650 (1%) 0% 1.2 337 Common Stock
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 882 172,933 (1%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 14 Feb 2020 283 172,051 (1%) 0% 2.9 829 Common Stock
Reginald L. Hardy Director, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 2,667 2,667 - - Stock Options
Reginald L. Hardy Director, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2020 883 172,334 (1%) 0% - Common Stock
Reginald L. Hardy Director, Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. 14 Feb 2020 1,426 171,451 (1%) 0% 1.2 1,654 Common Stock
George B. Abercrombie Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 8,764 8,764 - - Stock Options
George B. Abercrombie Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 2,167 2,167 - - Restricted Stock Units
Sanjeev Ahuja Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2019 83,313 83,313 - - Stock Options
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2018 105,000 105,000 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 8,000 8,000 - - Nonstatutory Stock Option (right to buy)
Thomas E. Shenk None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 36,775 36,775 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 68,225 68,225 - - Employee Stock Option (right to buy)
Larry Smith Sr VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 8,467 8,467 - - Nonstatutory Stock Option (right to buy)
Larry Smith Sr VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 51,533 51,533 - - Employee Stock Option (right to buy)
Anthony A. Ramos VP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 14,562 14,562 - - Nonstatutory Stock Option (right to buy)
Anthony A. Ramos VP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 55,438 55,438 - - Employee Stock Option (right to buy)
Mammen P. Mammen Sr VP, Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 57,158 57,158 - - Employee Stock Option (right to buy)
Mammen P. Mammen Sr VP, Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2018 12,842 12,842 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Purchase of securities on an exchange or from another person at price $ 1.75 per share. 10 Nov 2017 85,700 95,451 (0%) 0% 1.8 149,975 Common Stock $.01 par value
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 8,000 8,000 - - Nonstatutory Stock Option (right to buy)
Thomas E. Shenk None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 25,000 25,000 - - Nonstatutory Stock Option (right to buy)
Larry Smith Sr VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 10,000 10,000 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
Anthony A. Ramos VP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 10,000 10,000 - - Nonstatutory Stock Option (right to buy)
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 6,500 6,500 - - Nonstatutory Stock Option (right to buy)
Mammen P. Mammen Sr VP, Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2017 10,000 10,000 - - Nonstatutory Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 2.17 per share. 27 Mar 2017 4,250 9,674 (0%) 0% 2.2 9,240 Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 2.31 per share. 15 Mar 2017 875 17,696 (0%) 0% 2.3 2,021 Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 2.26 per share. 10 Feb 2017 4,500 18,571 (0%) 0% 2.3 10,160 Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 21,854 50,000 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 28,146 28,146 - - Employee Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 80,000 80,000 - - Nonstatutory Stock Option (right to buy)
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 25,000 25,000 - - Employee Stock Option (right to buy)
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 1,177 20,000 - - Nonstatutory Stock Option (right to buy)
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 18,823 18,823 - - Employee Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 787 20,000 - - Nonstatutory Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 25,000 25,000 - - Employee Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2017 19,213 19,213 - - Employee Stock Option (right to buy)
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 2.48 per share. 11 Jan 2017 54 23,071 (0%) 0% 2.5 134 Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 2.45 per share. 10 Jan 2017 5,763 91,170 (0%) 0% 2.4 14,114 Common Stock $.01 par value
Robert C. Merton None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Dec 2016 2,000 9,751 - - Common Stock $.01 par value
Robert C. Merton None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Dec 2016 2,000 11,751 - - Common Stock $.01 par value
Robert C. Merton None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Dec 2016 2,327 15,751 - - Common Stock $.01 par value
Robert C. Merton None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Dec 2016 2,000 13,751 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 11,050 101,582 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 4,649 96,933 - - Common Stock $.01 par value
R. Gordon Douglas None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 10,078 10,828 - - Common Stock $.01 par value
Gary A. Lyons None Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Dec 2016 7,078 7,828 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Oct 2016 54 23,125 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jul 2016 54 23,179 - - Common Stock $.01 par value
Robert C. Merton None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 4,100 18,078 - - Common Stock $.01 par value
Robert C. Merton None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 4,900 13,978 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2016 15,700 112,632 - - Common Stock $.01 par value
R. Gordon Douglas None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2016 10,078 20,906 - - Common Stock $.01 par value
Gary A. Lyons None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jun 2016 7,078 14,906 - - Common Stock $.01 par value
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2016 65,000 65,000 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2016 212,500 212,500 - - Nonstatutory Stock Option (right to buy)
Thomas E. Shenk None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2016 65,000 65,000 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2016 65,000 65,000 - - Nonstatutory Stock Option (right to buy)
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2016 80,000 80,000 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2016 65,000 65,000 - - Nonstatutory Stock Option (right to buy)
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2016 65,000 65,000 - - Nonstatutory Stock Option (right to buy)
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Mar 2016 8,750 232,331 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2016 17,600 989,226 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2016 5,900 969,326 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2016 14,000 975,226 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Feb 2016 7,500 139,235 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Jan 2016 193 146,735 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 225,756 225,756 - - Employee Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 199,244 425,000 - - Nonstatutory Stock Option (right to buy)
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 20,071 250,000 - - Nonstatutory Stock Option (right to buy)
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 229,929 229,929 - - Employee Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 67,888 300,000 - - Nonstatutory Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 232,112 232,112 - - Employee Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jan 2016 48,535 1,018,028 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jan 2016 11,202 1,006,826 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jan 2016 974 241,081 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jan 2016 75,000 1,066,563 - - Common Stock $.01 par value
Thomas E. Shenk None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2015 60,000 60,000 - - Nonstatutory Stock Option (right to buy)
Thomas E. Shenk None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2015 10,000 10,000 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Oct 2015 193 146,928 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Oct 2015 4,738 1,141,563 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Oct 2015 974 242,055 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Jul 2015 194 147,121 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Jul 2015 4,737 1,146,301 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Jul 2015 974 243,029 - - Common Stock $.01 par value
Igor Bilinsky Sr VP, Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Jul 2015 1,258 193,798 - - Common Stock $.01 par value
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 7,500 27,347 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 125,000 125,000 - - Nonstatutory Stock Option (right to buy)
Stephen A. Sherwin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Stephen A. Sherwin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 7,500 22,003 - - Common Stock $.01 par value
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 7,500 78,281 - - Common Stock $.01 par value
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 65,000 65,000 - - Nonstatutory Stock Option (right to buy)
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 7,500 108,281 - - Common Stock $.01 par value
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 7,500 90,781 - - Common Stock $.01 par value
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2015 7,500 22,078 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Apr 2015 193 147,315 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2015 4,738 1,151,038 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2015 974 244,003 - - Common Stock $.01 par value
Igor Bilinsky Sr VP, Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2015 1,257 195,056 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Mar 2015 55,000 1,155,776 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Jan 2015 428 147,508 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 78,394 78,394 - - Employee Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 171,606 250,000 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 300,000 1,210,776 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 67,500 67,500 - - Employee Stock Option (right to buy)
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 52,500 120,000 - - Nonstatutory Stock Option (right to buy)
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 70,000 244,977 - - Common Stock $.01 par value
Igor Bilinsky Sr VP, Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 78,751 78,751 - - Employee Stock Option (right to buy)
Igor Bilinsky Sr VP, Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 61,249 140,000 - - Nonstatutory Stock Option (right to buy)
Igor Bilinsky Sr VP, Corporate Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 70,000 196,313 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 56,250 56,250 - - Employee Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 43,750 100,000 - - Nonstatutory Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2015 60,000 147,936 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Jan 2015 4,737 910,776 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Jan 2015 1,912 174,977 - - Common Stock $.01 par value
Igor Bilinsky Sr VP, Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Jan 2015 1,335 126,313 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 26 Dec 2014 5,300 915,513 - - Common Stock
Vijay B. Samant Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 22 Dec 2014 15,379 921,134 - - Common Stock
Vijay B. Samant Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 22 Dec 2014 321 920,813 - - Common Stock
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2014 175,000 175,000 - - Nonstatutory Stock Option (right to buy)
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Oct 2014 428 87,936 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Oct 2014 4,738 936,513 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Oct 2014 1,912 176,889 - - Common Stock $.01 par value
Igor Bilinsky Sr VP, Corporate Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Oct 2014 1,335 127,648 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Aug 2014 12,500 178,801 - - Common Stock $.01 par value
Igor Bilinsky Senior VP, Corporate Devt Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Aug 2014 12,500 128,983 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Aug 2014 12,500 88,364 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Jul 2014 428 100,864 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Jul 2014 4,737 941,251 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jul 2014 1,912 191,301 - - Common Stock $.01 par value
Igor Bilinsky Senior VP, Corporate Devt Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jul 2014 1,335 141,483 - - Common Stock $.01 par value
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 7,500 19,847 - - Common Stock $.01 par value
Stephen A. Sherwin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Stephen A. Sherwin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 7,500 14,503 - - Common Stock $.01 par value
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 7,500 70,781 - - Common Stock $.01 par value
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 65,000 65,000 - - Nonstatutory Stock Option (right to buy)
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 7,500 100,781 - - Common Stock $.01 par value
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 7,500 83,281 - - Common Stock $.01 par value
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 50,000 50,000 - - Nonstatutory Stock Option (right to buy)
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 7,500 14,578 - - Common Stock $.01 par value
Anthony A. Ramos VP, Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Apr 2014 428 101,292 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Apr 2014 4,738 945,988 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Apr 2014 1,912 193,213 - - Common Stock $.01 par value
Igor Bilinsky Senior VP, Corporate Devt Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Apr 2014 1,150 142,818 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 Jan 2014 82 101,929 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 Jan 2014 209 101,720 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Jan 2014 164 102,175 - - Common Stock
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Jan 2014 164 102,011 - - Common Stock
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 330,000 950,726 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 90,000 195,125 - - Common Stock $.01 par value
Igor Bilinsky Senior VP, Corporate Devt Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 90,000 143,968 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2014 70,000 102,339 - - Common Stock $.01 par value
Larry Smith VP, Vaccine Research Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2014 655 107,422 - - Common Stock $.01 par value
Igor Bilinsky Senior VP, Corporate Devt Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2014 54 55,692 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Nov 2013 7,918 32,339 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 Oct 2013 82 40,257 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Oct 2013 163 40,502 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Oct 2013 163 40,339 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 13 Oct 2013 1,463 632,211 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Oct 2013 2,621 633,674 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2013 150,000 359,600 - - Employee Stock Option (right to buy)
Anthony A. Ramos Chief Accounting Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Aug 2013 25,000 40,665 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 Aug 2013 13,527 127,583 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 05 Aug 2013 1,400 636,295 - - Common Stock
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 Jul 2013 83 15,665 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Jul 2013 164 15,748 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Jul 2013 164 15,912 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jul 2013 1,471 637,695 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jul 2013 2,635 639,166 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jul 2013 1,097 173,134 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jul 2013 592 172,542 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jul 2013 1,317 174,231 - - Common Stock $.01 par value
George J. Morrow None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 May 2013 5,953 12,347 - - Common Stock $.01 par value
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 39,619 75,894 - - Nonstatutory Stock Option (right to buy)
Stephen A. Sherwin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 40,176 40,176 - - Nonstatutory Stock Option (right to buy)
Stephen A. Sherwin None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 May 2013 7,003 7,003 - - Common Stock $.01 par value
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 39,619 284,678 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 May 2013 5,953 63,281 - - Common Stock $.01 par value
R. Gordon Douglas None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 May 2013 5,953 93,281 - - Common Stock $.01 par value
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 52,048 453,296 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 May 2013 5,953 75,781 - - Common Stock $.01 par value
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 39,619 298,741 - - Nonstatutory Stock Option (right to buy)
Richard M. Beleson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 40,176 40,176 - - Nonstatutory Stock Option (right to buy)
Richard M. Beleson None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 May 2013 7,003 7,078 - - Common Stock $.01 par value
Robert C. Merton None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2013 12,500 259,122 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2013 12,500 69,828 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Apr 2013 164 16,158 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Apr 2013 82 16,076 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 19 Apr 2013 164 16,322 - - Common Stock $.01 par value
Anthony A. Ramos Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2013 70,000 70,000 - - Stock Option (Right to Buy)
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Apr 2013 1,471 641,801 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Apr 2013 2,635 643,272 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Apr 2013 593 175,548 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Apr 2013 1,098 176,141 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Apr 2013 1,317 177,239 - - Common Stock $.01 par value
Jill M. Broadfoot Sr Vice President, CFO, Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 01 Apr 2013 38,121 145,649 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2013 35,250 2,012,250 - - Employee Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jan 2013 2,634 651,790 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jan 2013 5,883 645,907 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Jan 2013 84,600 654,424 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2013 446,750 2,459,000 - - Nonstatutory Stock Option (right to buy)
Alain P. Rolland Exec VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2013 97,163 822,000 - - Nonstatutory Stock Option (right to buy)
Alain P. Rolland Exec VP, Product Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Jan 2013 22,092 182,023 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jan 2013 1,097 180,926 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jan 2013 2,370 178,556 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2013 27,837 724,837 - - Employee Stock Option (right to buy)
Jill M. Broadfoot Sr Vice President, CFO, Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2013 123,515 915,109 - - Nonstatutory Stock Option (right to buy)
Jill M. Broadfoot Sr Vice President, CFO, Sec Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Jan 2013 27,060 234,935 - - Common Stock $.01 par value
Jill M. Broadfoot Sr Vice President, CFO, Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jan 2013 2,370 232,565 - - Common Stock $.01 par value
Jill M. Broadfoot Sr Vice President, CFO, Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2013 29,594 791,594 - - Employee Stock Option (right to buy)
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2013 1,316 160,699 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2013 768 159,931 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 19 Nov 2012 5,000 569,824 - - Common Stock
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 37,500 179,122 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 56,250 122,872 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 12,500 216,622 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 12,500 241,622 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 12,500 229,122 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 12,500 266,622 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 6,000 6,000 - - Common Stock
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 20,000 46,622 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 6,000 8,328 - - Common Stock
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 22,000 36,328 - - Common Stock
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 22,000 14,328 - - Common Stock
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 12,500 254,122 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Gift of securities by or to the insider at price $ 0.00 per share. 19 Oct 2012 56,250 66,622 - - Nonstatutory Stock Option (right to buy)
George J. Morrow None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Oct 2012 6,394 6,394 - - Common Stock $.01 par value
George J. Morrow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Oct 2012 36,275 36,275 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Oct 2012 2,635 574,824 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Oct 2012 1,098 162,015 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Oct 2012 768 163,113 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Oct 2012 1,318 163,881 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jul 2012 2,634 577,459 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Jul 2012 1,097 165,199 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Jul 2012 768 166,296 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jul 2012 1,317 167,064 - - Common Stock $.01 par value
Robert H. Campbell None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 May 2012 7,328 58,328 - - Common Stock $.01 par value
Robert H. Campbell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2012 46,622 279,122 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2012 46,622 251,309 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 May 2012 7,328 57,328 - - Common Stock $.01 par value
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2012 61,248 421,248 - - Nonstatutory Stock Option (right to buy)
R. Gordon Douglas None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 May 2012 7,328 87,328 - - Common Stock $.01 par value
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2012 46,622 271,622 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 May 2012 7,328 57,328 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Apr 2012 2,633 580,093 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Apr 2012 1,097 168,381 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Apr 2012 768 169,478 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Apr 2012 1,317 170,246 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2012 33,473 1,773,473 - - Employee Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2012 328,527 2,102,000 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jan 2012 67,000 582,726 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jan 2012 27,000 171,563 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2012 29,875 639,875 - - Employee Stock Option (right to buy)
Alain P. Rolland Exec VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2012 117,125 757,000 - - Nonstatutory Stock Option (right to buy)
Jill M. Broadfoot Sr Vice President, CFO, Sec Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jan 2012 27,000 207,875 - - Common Stock $.01 par value
Jill M. Broadfoot Sr Vice President, CFO, Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2012 29,875 644,875 - - Employee Stock Option (right to buy)
Jill M. Broadfoot Sr Vice President, CFO, Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2012 117,125 762,000 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jan 2012 2,635 515,726 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jan 2012 1,098 144,563 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2012 5,269 146,429 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2012 768 145,661 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Jan 2012 109 151,698 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Oct 2011 2,632 518,361 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Oct 2011 767 152,903 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Oct 2011 1,096 151,807 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Oct 2011 109 153,670 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Jul 2011 2,636 520,993 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Jul 2011 768 154,877 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Jul 2011 1,098 153,779 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Jul 2011 109 155,645 - - Common Stock $.01 par value
Robert H. Campbell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2011 56,250 232,500 - - Nonstatutory Stock Option (right to buy)
Robert H. Campbell None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 May 2011 18,750 51,000 - - Common Stock $.01 par value
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2011 56,250 210,937 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 May 2011 18,750 50,000 - - Common Stock $.01 par value
R. Gordon Douglas None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 May 2011 30,000 80,000 - - Common Stock $.01 par value
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2011 90,000 380,000 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 May 2011 18,750 50,000 - - Common Stock $.01 par value
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2011 56,250 245,000 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Apr 2011 2,634 523,629 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Apr 2011 768 156,851 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Apr 2011 1,097 155,754 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Apr 2011 109 157,619 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Feb 2011 500 526,263 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Jan 2011 500 525,763 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Jan 2011 1,000 525,263 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Jan 2011 150,000 534,785 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2011 10,522 524,263 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 38,370 1,328,370 - - Employee Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 411,630 1,740,000 - - Nonstatutory Stock Option (right to buy)
Alain P. Rolland Exec VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 42,777 472,777 - - Employee Stock Option (right to buy)
Alain P. Rolland Exec VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 137,223 610,000 - - Nonstatutory Stock Option (right to buy)
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2011 4,384 157,727 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Jan 2011 60,000 162,877 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Jan 2011 766 162,111 - - Common Stock $.01 par value
Jill M. Broadfoot Sr Vice President, CFO, Sec Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Jan 2011 60,000 180,875 - - Common Stock $.01 par value
Jill M. Broadfoot Sr Vice President, CFO, Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 42,777 477,777 - - Employee Stock Option (right to buy)
Jill M. Broadfoot Sr Vice President, CFO, Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2011 137,223 615,000 - - Nonstatutory Stock Option (right to buy)
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 05 Jan 2011 657 384,785 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Jan 2011 109 103,008 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Jan 2011 131 102,877 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Dec 2010 1,000 385,442 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2010 1,000 384,442 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Nov 2010 1,000 383,442 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Oct 2010 767 103,118 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 05 Oct 2010 657 382,442 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Oct 2010 109 104,016 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Oct 2010 131 103,885 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Jul 2010 768 104,125 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 05 Jul 2010 658 383,099 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Jul 2010 109 105,024 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Jul 2010 131 104,893 - - Common Stock $.01 par value
Robert H. Campbell None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 May 2010 18,750 32,250 - - Common Stock $.01 par value
Robert H. Campbell None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 56,250 176,250 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 56,250 193,750 - - Nonstatutory Stock Option (right to buy)
Gary A. Lyons None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 May 2010 18,750 31,250 - - Common Stock $.01 par value
R. Gordon Douglas None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 90,000 310,000 - - Nonstatutory Stock Option (right to buy)
R. Gordon Douglas None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 May 2010 30,000 50,000 - - Common Stock $.01 par value
Robert C. Merton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2010 56,250 188,750 - - Nonstatutory Stock Option (right to buy)
Robert C. Merton None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 May 2010 18,750 31,250 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Apr 2010 768 105,133 - - Common Stock $.01 par value
Vijay B. Samant Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 05 Apr 2010 658 383,757 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Apr 2010 109 106,032 - - Common Stock $.01 par value
Alain P. Rolland Exec VP, Product Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Apr 2010 131 105,901 - - Common Stock $.01 par value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters